Clik here to view.
Taiyo Pacific Partners成为JIN Co., Ltd.的大股东，占股比例逾5%
东京 (美国商业资讯)–Taiyo Pacific Partners今天宣布，它累计持有的JIN Co., Ltd. (3046)股份已超过5%，成为JIN第三大股东。Taiyo Pacific Partners以与高管合作提高股东价值的合作型投资风格而著称。 Taiyo Pacific Partners首席执行官兼执行合伙人Brian K....
View ArticleClik here to view.
RetroSense Therapeutics Raises $6 million in an Over-Subscribed Series B...
ANN ARBOR, Mich. RetroSense Therapeutics, a privately-held, clinical-stage biopharmaceutical company, today announced that it has secured $6 million in a Series B financing to further investigate...
View ArticleClik here to view.
EYE TECH CARE宣布与中国投资者达成一项重要的注资和伙伴关系协议
法国里昂 (美国商业资讯) — EYE TECH CARE SA是一家开发和营销青光眼无创治疗眼科医疗器材的公司，该公司今天宣布已获得一家中国投资者的新一轮注资。恒松资本将分两轮投资，总金额约为2500万欧元，并将支持EYE TECH CARE的国际扩张。公司将受益于恒松资本在中国的布局，从而推进已经于2015年启动的产品报批。...
View ArticleClik here to view.
PENTAX Europe GmbH Acquires the Remaining Shares of PENTAX Italia S.r.L. from...
HAMBURG, Germany PENTAX Europe GmbH has acquired the remaining stock of PENTAX Italia S.r.L. from Movi S.p.A. This further investment by PENTAX Europe GmbH into the Italian healthcare market...
View ArticleClik here to view.
Hoya Reports Third Quarter Results; Record Nine Months Results
TOKYO Hoya Corporation (TOKYO: 7741) today announced financial results for the third quarter ended December 31, 2015. During the quarter, the Group sales totaled 127,645 million yen, decreasing by...
View ArticleClik here to view.
PENTAX Medical事業部長にジェラルド・W. ボッテロ が就任
東京 （ビジネスワイヤ） — HOYAグループPENTAX Medical事業部はこのたび、2016年2月1日付でジェラルド・W. ボッテロが医療用内視鏡の製造・販売を行うPENTAX Medical事業部長に就任したことを発表します。 HOYA株式会社 代表執行役最高経営責任者 (CEO)である鈴木 洋は、ボッテロの事業部長就任にあたり「ボッテロをPENTAX...
View ArticleClik here to view.
HOYA Group Appoints Gerald W. Bottero Global President of PENTAX Medical
TOKYO PENTAX Medical, a division of HOYA Group, has announced the appointment of Gerald W. Bottero to the position of Global President of PENTAX Medical as of February 1st, 2016. “HOYA Group is...
View ArticleClik here to view.
Glaukos Establishes Direct Sales Organization and Launches iStent inject®...
LAGUNA HILLS, Calif. Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to...
View ArticleClik here to view.
CORRECTING and REPLACING MEDIA ALERT: CSIRO to Host Silicon Valley Innovation...
PALO ALTO, Calif. Please replace the release dated February 11, 2016 with the following corrected version due to multiple revisions. The corrected release reads: MEDIA ALERT: CSIRO TO HOST SILICON...
View ArticleClik here to view.
InFo Instant Focus© – 天然晶状体手术治疗白内障的一次革命
瑞士纳沙泰尔 (美国商业资讯) — Swiss Advanced Vision公司 (SAV-IOL SA – www.sav-iol.com)宣布推出一款在医学界无与伦比的革命性产品。人工晶状体(IOL) InFo Instant Focus©适用于治疗白内障，可在摘除晶状体后彻底恢复视力，让患者仿佛重回20岁。 Smart News...
View ArticleClik here to view.
InFo Instant Focus© – 白内障の天然レンズ手術における革命
スイス・ヌーシャテル （ビジネスワイヤ） — Swiss Advanced Vision (SAV-IOL SA – www.sav-iol.com)は、医療分野で競合相手が存在しない製品の発売を発表しました。水晶体摘出後の白内障治療が適応の眼内レンズ（IOL）であるInFo Instant Focus©は、患者がまるで20歳の時のように完全な視覚を回復させます。 このSmart News...
View ArticleClik here to view.
豪雅集团任命Gerald W. Bottero为宾得医疗全球总裁
东京 (美国商业资讯) — 豪雅集团下属宾得医疗宣布任命Gerald W. Bottero为宾得医疗全球总裁，自2016年2月1日起生效。 豪雅集团总裁兼首席执行官Hiroshi Suzuki说：“豪雅集团很高兴由Gerald W....
View ArticleClik here to view.
Glaukos iStent® Trabecular Micro-Bypass Stent Approved in Japan
LAGUNA HILLS, Calif. Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to...
View ArticleClik here to view.
Announcement on Proposed Conversion of Japanese Subsidiary into the Holding...
SEATTLE Acucela Inc. (located in Seattle, Washington, U.S.A.; the “Company”) (TOKYO:4589), a clinical stage ophthalmology company that specializes in identifying and developing novel therapeutics to...
View ArticleClik here to view.
Quantel Medical Awarded Tender for Ophthalmic Laser Equipment from India...
CLERMONT-FERRAND, France Quantel Medical (Quantel), a global ophthalmic medical device company dedicated to developing leading technologies to improve the diagnosis and treatment of ocular diseases,...
View ArticleClik here to view.
クァンテル・メディカルがインド国防省から眼科レーザー装置の納入契約を落札
仏クレルモンフェラン （ビジネスワイヤ） — 眼科医療機器の世界的企業として眼疾患の診断・治療を改善する有力技術の開発に専心しているクァンテル・メディカル（クァンテル）は、眼科レーザー装置の競争入札で300万ユーロの契約を落札したと発表しました。...
View ArticleClik here to view.
Quantel Medical中标印度国防部眼科激光设备
法国克莱蒙费朗 (美国商业资讯) — Quantel Medical (Quantel) 是一家全球性眼科医疗器械公司，致力于开发各类领先技术，以改善眼科疾病的诊疗，该公司宣布已成功中标一批价值300万欧元眼科激光设备。 根据印度国防部武装力量医疗服务总局签署的供货协议条款，Quantel Medical将提供61台光凝固激光仪，供印度53家部队医院使用。配置Suprascan的532nm...
View ArticleClik here to view.
Acucela Licenses Gene Therapy from The University of Manchester for Retinal...
SEATTLE Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleClik here to view.
Acucela Announces End of Treatment Period in Phase 2b/3 Clinical Trial of...
SEATTLE Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleClik here to view.
Acucela to Present at ARVO 2016 Annual Meeting’s Education Courses in Seattle
SEATTLE Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View Article